Biotechnology stocks
Browse Biotechnology companies ranked by market cap with quality stock ratings for context.
Last updated on September 10, 2026
How this screen worksEvery company below clears all two criteria
IndustryBiotechnology
SortMarket cap, largest first
Biotechnology stocks
Top 50 of 607 companies
Quality rating| Company | Sector | Market cap | Quality rating | |
|---|---|---|---|---|
| Novo Nordisk | Healthcare | $195.2B | 9.2 | |
| Vertex Pharmaceuticals | Healthcare | $130.4B | 9.6 | |
| Regeneron Pharmaceuticals | Healthcare | $81.7B | 9.5 | |
| Argenx | Healthcare | $61.5B | 2.3 | |
| Moderna | Healthcare | $54.5B | 3.2 | |
| Revolution Medicines | Healthcare | $43.6B | 0.8 | |
| Beone Medicines | Healthcare | $38.9B | 6.5 | |
| Royalty Pharma | Healthcare | $33.8B | 5.8 | |
| Alnylam Pharmaceuticals | Healthcare | $33.1B | 9.0 | |
| Roivant Sciences | Healthcare | $29.6B | 1.6 | |
| Insmed | Healthcare | $27.8B | 4.7 | |
| Incyte | Healthcare | $25.0B | 8.6 | |
| Biontech | Healthcare | $24.4B | 6.1 | |
| United Therapeutics | Healthcare | $21.6B | 9.9 | |
| Genmab A | Healthcare | $20.1B | 8.9 | |
| Ascendis Pharma A | Healthcare | $17.2B | 5.1 | |
| Jazz Pharmaceuticals | Healthcare | $15.6B | 9.2 | |
| Exelixis | Healthcare | $14.2B | 10 | |
| Bridgebio Pharma | Healthcare | $14.2B | 3.0 | |
| Summit Therapeutics | Healthcare | $13.6B | 0.4 | |
| Biomarin Pharmaceutical | Healthcare | $12.7B | 3.8 | |
| Corcept Therapeutics | Healthcare | $12.4B | 7.5 | |
| Madrigal Pharmaceuticals | Healthcare | $12.3B | 3.7 | |
| Halozyme Therapeutics | Healthcare | $12.1B | 9.1 | |
| Arrowhead Pharmaceuticals | Healthcare | $11.7B | 4.7 | |
| Bio-Techne | Healthcare | $11.3B | 8.8 | |
| Axsome Therapeutics | Healthcare | $11.1B | 3.2 | |
| Cytokinetics | Healthcare | $10.2B | 0.9 | |
| Krystal Biotech | Healthcare | $10.2B | 7.5 | |
| Kymera Therapeutics | Healthcare | $9.7B | 1.9 | |
| Praxis Precision Medicines | Healthcare | $9.5B | 0.6 | |
| Protagonist Therapeutics | Healthcare | $9.4B | 6.9 | |
| Ionis Pharmaceuticals | Healthcare | $9.2B | 4.9 | |
| Abivax | Healthcare | $9.2B | 0.5 | |
| Vaxcyte | Healthcare | $8.8B | 2.1 | |
| Tg Therapeutics | Healthcare | $8.5B | 4.7 | |
| Immunitybio | Healthcare | $8.2B | 1.9 | |
| Immunovant | Healthcare | $7.9B | 0.8 | |
| Spyre Therapeutics | Healthcare | $7.8B | 0.7 | |
| Rhythm Pharmaceuticals | Healthcare | $7.0B | 2.8 | |
| Belite Bio | Healthcare | $6.9B | 0.9 | |
| Caris Life Sciences | Healthcare | $6.8B | 7.2 | |
| Scholar Rock Holding | Healthcare | $6.8B | 0.3 | |
| Mirum Pharmaceuticals | Healthcare | $6.5B | 3.7 | |
| Cg Oncology | Healthcare | $6.4B | 0.8 | |
| Travere Therapeutics | Healthcare | $6.4B | 6.0 | |
| Oruka Therapeutics | Healthcare | $6.1B | 0.7 | |
| Kiniksa Pharmaceuticals International | Healthcare | $6.0B | 6.9 | |
| Cogent Biosciences | Healthcare | $5.9B | 0.4 | |
| Dianthus Therapeutics | Healthcare | $5.8B | 0.7 |
Showing the top 50 of 607 matches.
See all 607 in the screener